Free shipping for order over $30

Continuous glucose monitoring (CGM) has revolutionized diabetes care, especially for people who require real-time and accurate blood glucose data to make daily lifestyle and treatment decisions. From type 1 to type 2 diabetes patients, CGM empowers better self-management, reduces the risk of hypoglycemia, and improves long-term health outcomes.

In this article, we’ll explore what CGM is, who can use it, and how our medical dressings and CGM adhesive patches help protect and extend the life of CGM devices.

Continuous Glucose Monitoring (CGM) and Diabetes: Why They Are Closely Connected

1. CGM as a Key Tool in Diabetes Management

For people living with diabetes—both type 1 and type 2—blood sugar variability, hypoglycemia, and hyperglycemia are constant challenges. CGM provides glucose readings every few minutes, even at night, offering a much more complete picture than traditional fingerstick testing.

The American Diabetes Association (ADA) states: “CGM use in both type 1 and type 2 diabetes is associated with lower HbA1c levels and fewer hypoglycemia events.”
�� ADA CGM Guidance 2025 (PDF)

2. Evidence: CGM Improves HbA1c and Glucose Control

Clinical studies have consistently shown that CGM helps reduce average glucose levels and improves glycemic outcomes:

A real-world study found that patients using professional CGM (p-CGM) reduced HbA1c by 0.83% (from 8.70% to 7.87%), compared to smaller reductions in non-CGM users.
�� Source: PubMed Central

Research published in the Journal of Managed Care & Specialty Pharmacy reported that type 2 diabetes patients initiating CGM saw an average HbA1c reduction of 0.7%.
�� JMCP Study

An ADA press release highlighted that in type 2 diabetes patients not on insulin, six months of CGM use led to a 0.5% decrease in glucose management indicator (GMI) and a 17% increase in Time in Range (TIR).
�� ADA Newsroom

3. Lowering Complications and Hospitalizations

CGM is not just about numbers—it helps reduce long-term risks:

The RELIEF study in France showed that nationwide adoption of FreeStyle Libre CGM systems significantly reduced diabetes-related hospitalizations and emergency room visits, improving both clinical outcomes and healthcare cost savings.

How Accurate Is Continuous Glucose Monitoring?

Accuracy is a major concern for users and clinicians. Let’s review what the literature says:

A meta-study of 22 trials (n = 2294 patients) showed that the average Mean Absolute Relative Difference (MARD) across currently available CGM devices was 9.4%. While devices are reasonably accurate in euglycemia and hyperglycemia ranges, their performance in hypoglycemia is still less robust (sensitivity ≈ 85.7%, specificity ≈ 95.3%). PubMed

In a real‐world hospital/clinical setting, CGM measurements compared with lab or point-of-care glucose references showed satisfactory agreement overall, but caution remains in fast-changing glucose conditions.

In a reproducibility study over multiple days, sensors demonstrated better accuracy during normal and high glucose ranges than in hypoglycemic ranges. For example, MARD ~ 7.8% in 70–180 mg/dL range; when glucose <70 mg/dL, error rates could be higher. Nature

For a 14-day CGM system (FreeStyle Libre 3), authors reported a MARD of 7.8%, with ~93.4% of readings falling within ±20 mg/dL or ±20% of the venous reference in participants aged ≥ 6 years. SpringerLink

Interpretation & caveats:

A MARD of ~7–10% is considered quite good in the field; many regulatory and clinical decisions now rely on CGM data without confirmatory fingersticks in stable ranges.

Accuracy tends to decrease during times of rapid glucose change (rising/falling) and in low glucose (hypo) zones.

Calibration, sensor lag time, and patient physiology can influence performance.

Users should understand the limitations (especially in hypoglycemia) and use CGM data alongside clinical judgment.

Thus, while CGM is not perfect, its accuracy is generally sufficient to guide therapy decisions in many contexts.

What Are the Benefits of Continuous Glucose Monitoring?

CGM offers multiple clinical, behavioral, and quality-of-life advantages over traditional self-monitoring of blood glucose (SMBG). Key benefits include:

Better Glycemic Control & HbA1c Reduction

In randomized controlled trials and meta-analyses, CGM use has been associated with HbA1c reductions of ~0.3–0.5% compared to fingerstick monitoring.

Because CGM reveals trends and excursions, users can make better-informed adjustments to insulin, diet, or lifestyle.

Increased Time in Range (TIR)

Time in Range (e.g. 70–180 mg/dL) is now a key metric in diabetes care. CGM users often see substantial increases in TIR, which correlates with reduced risk of complications.

For instance, in a Medicare trial, TIR improved from ~43% (fingerstick) to ~59% with CGM over 8 months. diabetes.org

Reduced Hypoglycemia & Hyperglycemia Events

Many CGM devices support alerts/alarms for high or low glucose, helping users respond before levels become dangerous.

Observational and controlled studies show reductions in the duration and severity of hypoglycemic episodes (though detection in severe hypoglycemia remains a challenge due to sensor limitations).

Enhanced Patient Engagement & Behavior Change

Users gain immediate feedback on how meals, exercise, stress, or medication changes influence glucose.

This real-time insight often leads to more proactive and precise self-management.

Psychological benefits: lower anxiety, fewer fingersticks, improved confidence in diabetes control.

Long-Term Health Protection

Better glycemic control and more stable glucose patterns may translate to lower risks of complications (retinopathy, nephropathy, neuropathy, cardiovascular issues) over time—as suggested by long-term diabetes outcome studies.CGM helps detect patterns that would be missed with periodic testing, enabling earlier intervention.

Smarter Diabetes Care with Reliable Protection

To get the full benefits of Continuous Glucose Monitoring (CGM), your sensor needs to stay in place for its entire wear period. That’s why a high-quality adhesive patch is essential.

Why Choose Our CGM Patch?

  • Elastic fabric for comfort during daily activities and exercise
  • Breathable, waterproof, and sweat-resistant to ensure long wear
  • Low-allergy acrylic adhesive suitable for sensitive skin
  • 10–14 day durability, matching most CGM sensor lifespans

Keep your CGM secure and reliable—whether you’re working out, swimming, or living your daily routine.

Explore our full medical dressing solutions at Ceeport Official Website.
Read more educational content on our Wound Care Blog.
Shop our specialized CGM Patches.

Conclusion

Continuous Glucose Monitoring (CGM) is transforming diabetes care with real-time insights, improved accuracy, and better health outcomes. But to fully benefit from CGM, your sensor must stay secure for its entire wear period. That’s where the right adhesive protection makes all the difference.

Our CGM Sensor Patches are designed with breathable, waterproof, and hypoallergenic materials to keep your device in place for up to 14 days—ensuring uninterrupted, reliable tracking.

�� Take the next step toward safer and more effective diabetes management. Shop CGM Sensor Patches here and protect your CGM today.